A keynote presenter at NCAD will reinforce the call for more tailored treatment
Carlton K. Erickson, PhD, acknowledges that today's conference attendees in the addiction professional community respond more positively to neurobiological clues about addiction than they did a generation ago, when his lectures tended to provoke arguments. Still, he wonders whether clinicians who today will nod their heads when presented with scientific data are effectively applying that knowledge in their everyday work with patients.
"Most catch on quickly now, but whether they actually practice it, I don't know, because no one has measured this," says Erickson, director of the Addiction Science Research and Education Center at the University of Texas College of Pharmacy.
Erickson will devote his keynote address at this September's inaugural National Conference on Addiction Disorders (NCAD) to a discussion of neurobiological factors that can inform excellent treatment. Part of the talk will focus on the clinical criteria for a diagnosis of substance dependence vs. a diagnosis of substance abuse, as Erickson believes this important distinction must continue to be reinforced in the field.
"It's extremely important to talk about this difference, because one's a brain disease and one is not," Erickson says. "We know that the good centers are assessing for this difference and are generally admitting people who are dependent. They want their treatment to focus on the people who are the most ill - they feel that's the best use of their limited resources."
NCAD, to be held Sept. 8-11 in Washington, D. C, is being produced by Vendome Group, publisher of Addiction Professional, as an event combining treatment, administration, design, technology and other information for the addiction treatment community. Vendome has founded the event in conjunction with NAADAC, the Association for Addiction Professionals and the National Association of Addiction Treatment Providers (NAATP).
NAADAC's annual meeting now will be held under the NCAD title going forward. Also participating as an organizer of this year's conference is the International Coalition for Addiction Studies Education (INCASE). Targeted audiences for the conference include counselors, physicians, nurses and addiction treatment program executives.
Erickson believes many treatment programs might be treating a large number of individuals who do not meet clinical criteria for the disease of addiction (i.e., for dependence). "All they see is chis general sense that a person has a drug problem, and all they want to do is help," he says.
Erickson thinks others might actually target non-dependent individuals. He believes, for instance, that treatment centers that emphasize to potential clients their spa-like services have to be treating a non-addicted population if they are showing much success. "You can't change a brain disease with better food and more relaxation," he says.
He is particularly troubled by the removal of the specific distinction between dependence and abuse in the draft of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders. …